205 related articles for article (PubMed ID: 30705288)
1. Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer's disease.
Dalmasso MC; Brusco LI; Olivar N; Muchnik C; Hanses C; Milz E; Becker J; Heilmann-Heimbach S; Hoffmann P; Prestia FA; Galeano P; Avalos MSS; Martinez LE; Carulla ME; Azurmendi PJ; Liberczuk C; Fezza C; Sampaño M; Fierens M; Jemar G; Solis P; Medel N; Lisso J; Sevillano Z; Bosco P; Bossù P; Spalletta G; Galimberti D; Mancuso M; Nacmias B; Sorbi S; Mecocci P; Pilotto A; Caffarra P; Panza F; Bullido M; Clarimon J; Sánchez-Juan P; Coto E; Sanchez-Garcia F; Graff C; Ingelsson M; Bellenguez C; Castaño EM; Kairiyama C; Politis DG; Kochen S; Scaro H; Maier W; Jessen F; Mangone CA; Lambert JC; Morelli L; Ramirez A
Transl Psychiatry; 2019 Jan; 9(1):55. PubMed ID: 30705288
[TBL] [Abstract][Full Text] [Related]
2. Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.
Olive C; Ibanez L; Farias FHG; Wang F; Budde JP; Norton JB; Gentsch J; Morris JC; Li Z; Dube U; Del-Aguila J; Bergmann K; Bradley J; Benitez BA; Harari O; Fagan A; Ances B; Cruchaga C; Fernandez MV
J Alzheimers Dis; 2020; 77(4):1469-1482. PubMed ID: 32894242
[TBL] [Abstract][Full Text] [Related]
3. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
Sims R; van der Lee SJ; Naj AC; Bellenguez C; Badarinarayan N; Jakobsdottir J; Kunkle BW; Boland A; Raybould R; Bis JC; Martin ER; Grenier-Boley B; Heilmann-Heimbach S; Chouraki V; Kuzma AB; Sleegers K; Vronskaya M; Ruiz A; Graham RR; Olaso R; Hoffmann P; Grove ML; Vardarajan BN; Hiltunen M; Nöthen MM; White CC; Hamilton-Nelson KL; Epelbaum J; Maier W; Choi SH; Beecham GW; Dulary C; Herms S; Smith AV; Funk CC; Derbois C; Forstner AJ; Ahmad S; Li H; Bacq D; Harold D; Satizabal CL; Valladares O; Squassina A; Thomas R; Brody JA; Qu L; Sánchez-Juan P; Morgan T; Wolters FJ; Zhao Y; Garcia FS; Denning N; Fornage M; Malamon J; Naranjo MCD; Majounie E; Mosley TH; Dombroski B; Wallon D; Lupton MK; Dupuis J; Whitehead P; Fratiglioni L; Medway C; Jian X; Mukherjee S; Keller L; Brown K; Lin H; Cantwell LB; Panza F; McGuinness B; Moreno-Grau S; Burgess JD; Solfrizzi V; Proitsi P; Adams HH; Allen M; Seripa D; Pastor P; Cupples LA; Price ND; Hannequin D; Frank-García A; Levy D; Chakrabarty P; Caffarra P; Giegling I; Beiser AS; Giedraitis V; Hampel H; Garcia ME; Wang X; Lannfelt L; Mecocci P; Eiriksdottir G; Crane PK; Pasquier F; Boccardi V; Henández I; Barber RC; Scherer M; Tarraga L; Adams PM; Leber M; Chen Y; Albert MS; Riedel-Heller S; Emilsson V; Beekly D; Braae A; Schmidt R; Blacker D; Masullo C; Schmidt H; Doody RS; Spalletta G; Longstreth WT; Fairchild TJ; Bossù P; Lopez OL; Frosch MP; Sacchinelli E; Ghetti B; Yang Q; Huebinger RM; Jessen F; Li S; Kamboh MI; Morris J; Sotolongo-Grau O; Katz MJ; Corcoran C; Dunstan M; Braddel A; Thomas C; Meggy A; Marshall R; Gerrish A; Chapman J; Aguilar M; Taylor S; Hill M; Fairén MD; Hodges A; Vellas B; Soininen H; Kloszewska I; Daniilidou M; Uphill J; Patel Y; Hughes JT; Lord J; Turton J; Hartmann AM; Cecchetti R; Fenoglio C; Serpente M; Arcaro M; Caltagirone C; Orfei MD; Ciaramella A; Pichler S; Mayhaus M; Gu W; Lleó A; Fortea J; Blesa R; Barber IS; Brookes K; Cupidi C; Maletta RG; Carrell D; Sorbi S; Moebus S; Urbano M; Pilotto A; Kornhuber J; Bosco P; Todd S; Craig D; Johnston J; Gill M; Lawlor B; Lynch A; Fox NC; Hardy J; ; Albin RL; Apostolova LG; Arnold SE; Asthana S; Atwood CS; Baldwin CT; Barnes LL; Barral S; Beach TG; Becker JT; Bigio EH; Bird TD; Boeve BF; Bowen JD; Boxer A; Burke JR; Burns JM; Buxbaum JD; Cairns NJ; Cao C; Carlson CS; Carlsson CM; Carney RM; Carrasquillo MM; Carroll SL; Diaz CC; Chui HC; Clark DG; Cribbs DH; Crocco EA; DeCarli C; Dick M; Duara R; Evans DA; Faber KM; Fallon KB; Fardo DW; Farlow MR; Ferris S; Foroud TM; Galasko DR; Gearing M; Geschwind DH; Gilbert JR; Graff-Radford NR; Green RC; Growdon JH; Hamilton RL; Harrell LE; Honig LS; Huentelman MJ; Hulette CM; Hyman BT; Jarvik GP; Abner E; Jin LW; Jun G; Karydas A; Kaye JA; Kim R; Kowall NW; Kramer JH; LaFerla FM; Lah JJ; Leverenz JB; Levey AI; Li G; Lieberman AP; Lunetta KL; Lyketsos CG; Marson DC; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam M; Miller BL; Miller CA; Miller JW; Morris JC; Murrell JR; Myers AJ; O'Bryant S; Olichney JM; Pankratz VS; Parisi JE; Paulson HL; Perry W; Peskind E; Pierce A; Poon WW; Potter H; Quinn JF; Raj A; Raskind M; Reisberg B; Reitz C; Ringman JM; Roberson ED; Rogaeva E; Rosen HJ; Rosenberg RN; Sager MA; Saykin AJ; Schneider JA; Schneider LS; Seeley WW; Smith AG; Sonnen JA; Spina S; Stern RA; Swerdlow RH; Tanzi RE; Thornton-Wells TA; Trojanowski JQ; Troncoso JC; Van Deerlin VM; Van Eldik LJ; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Wilhelmsen KC; Williamson J; Wingo TS; Woltjer RL; Wright CB; Yu CE; Yu L; Garzia F; Golamaully F; Septier G; Engelborghs S; Vandenberghe R; De Deyn PP; Fernadez CM; Benito YA; Thonberg H; Forsell C; Lilius L; Kinhult-Stählbom A; Kilander L; Brundin R; Concari L; Helisalmi S; Koivisto AM; Haapasalo A; Dermecourt V; Fievet N; Hanon O; Dufouil C; Brice A; Ritchie K; Dubois B; Himali JJ; Keene CD; Tschanz J; Fitzpatrick AL; Kukull WA; Norton M; Aspelund T; Larson EB; Munger R; Rotter JI; Lipton RB; Bullido MJ; Hofman A; Montine TJ; Coto E; Boerwinkle E; Petersen RC; Alvarez V; Rivadeneira F; Reiman EM; Gallo M; O'Donnell CJ; Reisch JS; Bruni AC; Royall DR; Dichgans M; Sano M; Galimberti D; St George-Hyslop P; Scarpini E; Tsuang DW; Mancuso M; Bonuccelli U; Winslow AR; Daniele A; Wu CK; ; Peters O; Nacmias B; Riemenschneider M; Heun R; Brayne C; Rubinsztein DC; Bras J; Guerreiro R; Al-Chalabi A; Shaw CE; Collinge J; Mann D; Tsolaki M; Clarimón J; Sussams R; Lovestone S; O'Donovan MC; Owen MJ; Behrens TW; Mead S; Goate AM; Uitterlinden AG; Holmes C; Cruchaga C; Ingelsson M; Bennett DA; Powell J; Golde TE; Graff C; De Jager PL; Morgan K; Ertekin-Taner N; Combarros O; Psaty BM; Passmore P; Younkin SG; Berr C; Gudnason V; Rujescu D; Dickson DW; Dartigues JF; DeStefano AL; Ortega-Cubero S; Hakonarson H; Campion D; Boada M; Kauwe JK; Farrer LA; Van Broeckhoven C; Ikram MA; Jones L; Haines JL; Tzourio C; Launer LJ; Escott-Price V; Mayeux R; Deleuze JF; Amin N; Holmans PA; Pericak-Vance MA; Amouyel P; van Duijn CM; Ramirez A; Wang LS; Lambert JC; Seshadri S; Williams J; Schellenberg GD
Nat Genet; 2017 Sep; 49(9):1373-1384. PubMed ID: 28714976
[TBL] [Abstract][Full Text] [Related]
4. ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans.
Conway OJ; Carrasquillo MM; Wang X; Bredenberg JM; Reddy JS; Strickland SL; Younkin CS; Burgess JD; Allen M; Lincoln SJ; Nguyen T; Malphrus KG; Soto AI; Walton RL; Boeve BF; Petersen RC; Lucas JA; Ferman TJ; Cheshire WP; van Gerpen JA; Uitti RJ; Wszolek ZK; Ross OA; Dickson DW; Graff-Radford NR; Ertekin-Taner N
Mol Neurodegener; 2018 Oct; 13(1):53. PubMed ID: 30326945
[TBL] [Abstract][Full Text] [Related]
5. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
Lu Y; Liu W; Wang X
Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
[TBL] [Abstract][Full Text] [Related]
6. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy.
Strickland SL; Morel H; Prusinski C; Allen M; Patel TA; Carrasquillo MM; Conway OJ; Lincoln SJ; Reddy JS; Nguyen T; Malphrus KG; Soto AI; Walton RL; Crook JE; Murray ME; Boeve BF; Petersen RC; Lucas JA; Ferman TJ; Uitti RJ; Wszolek ZK; Ross OA; Graff-Radford NR; Dickson DW; Ertekin-Taner N
Acta Neuropathol Commun; 2020 Oct; 8(1):172. PubMed ID: 33092647
[TBL] [Abstract][Full Text] [Related]
7. Lack of genetic association between TREM2 and Alzheimer's disease in East Asian population: a systematic review and meta-analysis.
Huang M; Wang D; Xu Z; Xu Y; Xu X; Ma Y; Xia Z
Am J Alzheimers Dis Other Demen; 2015 Sep; 30(6):541-6. PubMed ID: 25852195
[TBL] [Abstract][Full Text] [Related]
8.
Durmanova V; Javor J; Parnicka Z; Minarik G; Ocenasova A; Vaseckova B; Kiralyova I; Sutovsky S; Petrovic R; Shawkatova I
J Integr Neurosci; 2022 Jun; 21(4):105. PubMed ID: 35864757
[TBL] [Abstract][Full Text] [Related]
9. TREM2 is associated with the risk of Alzheimer's disease in Spanish population.
Benitez BA; Cooper B; Pastor P; Jin SC; Lorenzo E; Cervantes S; Cruchaga C
Neurobiol Aging; 2013 Jun; 34(6):1711.e15-7. PubMed ID: 23391427
[TBL] [Abstract][Full Text] [Related]
10. TREM2 variants in Alzheimer's disease.
Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J;
N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934
[TBL] [Abstract][Full Text] [Related]
11. Coding variants in TREM2 increase risk for Alzheimer's disease.
Jin SC; Benitez BA; Karch CM; Cooper B; Skorupa T; Carrell D; Norton JB; Hsu S; Harari O; Cai Y; Bertelsen S; Goate AM; Cruchaga C
Hum Mol Genet; 2014 Nov; 23(21):5838-46. PubMed ID: 24899047
[TBL] [Abstract][Full Text] [Related]
12. A rare coding variant in TREM2 increases risk for Alzheimer's disease in Han Chinese.
Jiang T; Tan L; Chen Q; Tan MS; Zhou JS; Zhu XC; Lu H; Wang HF; Zhang YD; Yu JT
Neurobiol Aging; 2016 Jun; 42():217.e1-3. PubMed ID: 27067662
[TBL] [Abstract][Full Text] [Related]
13. Association of Rare Coding Mutations With Alzheimer Disease and Other Dementias Among Adults of European Ancestry.
Patel D; Mez J; Vardarajan BN; Staley L; Chung J; Zhang X; Farrell JJ; Rynkiewicz MJ; Cannon-Albright LA; Teerlink CC; Stevens J; Corcoran C; Gonzalez Murcia JD; Lopez OL; Mayeux R; Haines JL; Pericak-Vance MA; Schellenberg G; Kauwe JSK; Lunetta KL; Farrer LA;
JAMA Netw Open; 2019 Mar; 2(3):e191350. PubMed ID: 30924900
[TBL] [Abstract][Full Text] [Related]
14. Genetic Analysis of TREM2 Variants in Tunisian Patients with Alzheimer's Disease.
Landoulsi Z; Ben Djebara M; Kacem I; Sidhom Y; Kefi R; Abdelhak S; Gargouri-Berrechid A; Gouider R
Med Princ Pract; 2018; 27(4):317-322. PubMed ID: 29723869
[TBL] [Abstract][Full Text] [Related]
15. The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.
Lill CM; Rengmark A; Pihlstrøm L; Fogh I; Shatunov A; Sleiman PM; Wang LS; Liu T; Lassen CF; Meissner E; Alexopoulos P; Calvo A; Chio A; Dizdar N; Faltraco F; Forsgren L; Kirchheiner J; Kurz A; Larsen JP; Liebsch M; Linder J; Morrison KE; Nissbrandt H; Otto M; Pahnke J; Partch A; Restagno G; Rujescu D; Schnack C; Shaw CE; Shaw PJ; Tumani H; Tysnes OB; Valladares O; Silani V; van den Berg LH; van Rheenen W; Veldink JH; Lindenberger U; Steinhagen-Thiessen E; ; Teipel S; Perneczky R; Hakonarson H; Hampel H; von Arnim CAF; Olsen JH; Van Deerlin VM; Al-Chalabi A; Toft M; Ritz B; Bertram L
Alzheimers Dement; 2015 Dec; 11(12):1407-1416. PubMed ID: 25936935
[TBL] [Abstract][Full Text] [Related]
16. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
[TBL] [Abstract][Full Text] [Related]
17. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
[TBL] [Abstract][Full Text] [Related]
18. PLCG2 rs72824905 Variant Reduces the Risk of Alzheimer's Disease and Multiple Sclerosis.
Chen F; Zhang Y; Wang L; Wang T; Han Z; Zhang H; Gao S; Hu Y; Liu G
J Alzheimers Dis; 2021; 80(1):71-77. PubMed ID: 33523007
[TBL] [Abstract][Full Text] [Related]
19. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S
Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042
[TBL] [Abstract][Full Text] [Related]
20. Identification of a rare coding variant in TREM2 in a Chinese individual with Alzheimer's disease.
Bonham LW; Sirkis DW; Fan J; Aparicio RE; Tse M; Ramos EM; Wang Q; Coppola G; Rosen HJ; Miller BL; Yokoyama JS
Neurocase; 2017 Feb; 23(1):65-69. PubMed ID: 28376694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
